Text :: Skip Nav ::
2011-05-25: We appreciate your patience while we work on this page.
Informed Consent Protocol No. A4091016 A Phase 3 Multicenter Randomized Long Term Study of the Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip 2009-09-10: http://www.circare.org/consents/a4091016_20090910.pdf
Informed Consent Protocol No. A4091016 A Phase 3 Multicenter Randomized Long Term Study of the Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip 2010-07-26: http://www.circare.org/consents/a4091016_20100726.pdf
UPDATE 2-Pfizer halts clinical trials of arthritis drug. Bill Berkrot. Reuters 2010-06-23: http://www.reuters.com/article/2010/06/23/pfizer-arthritis-idUSN2320755920100623
If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Find out more on our Support page
All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education. Adobe® Reader :: ::